Doximity Announces Fiscal 2022 Second Quarter Financial Results

Go back to Doximity Announces Fiscal 2022 Second Quarter Financial Results

Doximity Inc (DOCS) PT Raised to $90 at Needham & Company

November 10, 2021 6:57 AM EST

Needham & Company analyst Scott Berg raised the price target on Doximity Inc (NYSE: DOCS) to $90.00 (from $62.00) while maintaining a Buy rating.

The analyst commented, "DOCS reported very good 2Q financial results including an 8% revenue beat and a 10% increase in FY22 revenue guidance. Overall... More

Doximity, Inc. (DOCS) Tops Q2 EPS by 9c; Guides Above

November 9, 2021 4:18 PM EST

Doximity, Inc. (NYSE: DOCS) reported Q2 EPS of $0.19, $0.09 better than the analyst estimate of $0.10. Revenue for the quarter came in at $79.4 million versus the consensus estimate of $73.5 million.

GUIDANCE:

Doximity, Inc. sees Q3 2022 revenue of $85.8-86.8 million, versus the consensus of... More